Clinical Trial Management
Contract Development and Manufacturing
Decentralized Clinical Trials
European Medicines Agency
Hybrid Clinical Trials
In-Vitro Diagnostic Regulation
Outsourcing Clinical Trials
Rare Disease Trials
Research & Development
Research and Development
Relative Weight of the Variables Evaluated Through the Therapeutic Positioning Reports in the Pricing and Reimbursement of Oncological and Oncohematology Medicines in Spain
Discover how companies’ target prices are impacted by the different variables leveraged during the P&R process for oncology and oncohematology’s first indication.
White Paper: Next Generation Therapies: Access, Pricing and Ethical Issues in Perspective
In this white paper, we will explore wide range of new therapies we term “Next Generation Therapies” and challenges related to them.
Real-World Evidence: Five Facts You Need to Know
Learn more about RWD and its future challenges for Europe, we asked Romain Finas, Vice President of Real-World Evidence (RWE) at Alira Health, to share five facts that you need to know about it.
Early Access Programs: Keys to Success
Discover Alira Health’s top five recommendations to building a successful Early Access Programs (EAP).
Next Generation Therapies: Access, Pricing, and Challenges
Learn more about Next Generation Therapies that have the potential to disrupt the biopharmaceutical environment.
Trend Outlook: Fostering Innovation and the Importance of Market Access
Interview with Robert Fabregat, CEO of Biocat, and Chus Castillo, Director of Global Market Access at Alira Health, to understand how companies can foster innovation locally and globally,(...)
White Paper: Enhancing Patient Access with Early Access Programs
Pharmaceutical companies are facing an increasing demand from physicians for Early Access Programs (EAPs) and are willing to make their innovative medicines available to patients with(...)
Alira Health Published in Business Development & Licensing Journal
Experts from the Alira Health team recently shared their thoughts regarding the importance of market access insights for the success of licensing operations with professionals from(...)
Health Economics Evaluation and Value Proposition for an Antimicrobial Medical Device in the U.S. Market
A health economics evaluation assists companies during product development to better understand the product's impact across the ecosystem and position it appropriately.
Critical Success Factors in Market Access
Today’s MedTech market is more concentrated than ever, with critical factors that need to be examined to advance a new product.
WHO Guideline: Summary of Recommendations on Pharmaceutical Pricing Policies
The WHO recently launched a series of recommendations on pharmaceutical pricing policies to help countries make medicines more affordable for the global population and lessen the burden(...)
Our Parallel Trade Expertise
Alira Health is proud to announce our new collaboration with Mark Inigo Jones, an industry leader in European parallel trade of pharmaceutical products.
Assessment of POCT Device Potential and Definition of a Go -To- Market Strategy for Selected Countries in South America
When our client, an Asia-based medtech company with a novel POCT solution, wanted to understand the best market access strategy to enter into Latin America, Alira Health shed light(...)
Latest from Alira Health
Spain Healthcare Innovation Summit 2022
We are pleased to join the Spain Healthcare Innovation Summit as sponsors and speakers. Join our speaker Manuel Vázquez Roso, Director Market Access, for the panel “El Rol de la(...)
PHUSE EU 2022
We are pleased to announce that we will be joining as sponsors and delegates PHUSE EU, an event that brings together the PHUSE global community to collaborate on hot topics guiding(...)
ISPOR EU 2022
We are excited to announce that we will be joining ISPOR EU 2022, the leading global conference for Health Economics and Outcomes Research.
Webinar: Health Economic and Outcome Research (HEOR) for Medical Technologies for the US Healthcare Systems
A well-designed Health Economics and Outcomes Research (HEOR) study is vital for generating short- and long-term effectiveness data. Attend the webinar to gain a stepwise strategic(...)
RARECast: Leveraging Technology to Empower Patients and Decentralize Clinical Trials
Technology plays a central role in the future of patient empowerment and decentralized clinical trials. Listen to the podcast to learn more.
Exclusive MedTech Webinar Series “Expanding Beyond APAC”
Join this series of webinars to learn about the strategies, challenges, and best practices of scaling beyond the Asia Pacific MedTech market.
Alira Health Partners with Policy Matters to Foster Market Access in the UK
Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announces its partnership with leading UK market access specialist(...)
Alira Health and GDMH together to boost Life Sciences innovation
The companies join forces for collaborative research and co-development of projects in the fields of Digital Health, Real-World Evidence and Market Access.
Alira Health enhances its market access services through a strategic partnership with Centivis
Alira Health, a global healthcare advisory and technology company, announced a strategic partnership with Centivis AG, a boutique market access consulting agency, specializing in digital(...)